Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes

Clinical Infectious Diseases

Volumn 28, Issue 5, 1999, Pages 1017-1024

  Friedrich, Lawrence V ^a   White, Roger L ^a   Bosso, John A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG USE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE ANAEROBIC BACTERIA; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

EID: 0032938888     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514747     Document Type: Article

References (38)

1. 1. Report of the ASM Task Force on Antibiotic Resistance. Washington, DC: American Society for Microbiology, 1995.
2. 2. Kunin CM. Resistance to antimicrobial drugs - a worldwide calamity [editorial]. Ann Intern Med 1993;118:557-61.
3. 3. Tenover FC, Hughes JM. Development and spread of multiply-resistant bacterial pathogens. JAMA 1996;275:300-4.
4. 4. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050-5.
5. 5. O'Brien TF. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis 1997;24(suppl 1):2S-8S.
6. 6. Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis 1997;24(suppl 1):139S-45S.
7. 7. Gaynes R. Antibiotic resistance in ICUs: a multifaceted problem requiring a multifaceted solution. Infect Control Hosp Epidemiol 1995;16: 328-30.
8. 8. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997;11: 757-65.
9. 9. Gaynes R, Monnet D. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals. Ciba Found Symp 1997;207: 47-60.
10. 10. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
11. 11. Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-99.
12. 12. McGowan JE, Tenover FC. Control of antimicrobial resistance in the healthcare system. Infect Dis Clin North Am 1997;11:297-311.
13. 13. McGowan JE. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15:478-83.
14. 14. White RL, Burgess DS, Friedrich LV. Analysis of multiple antimicrobial usage on changes in susceptibility of gram-negative aerobes [abstract no 55]. Pharmacotherapy 1992;12:252.
15. 15. Balague M, Del Valle O, Figueras A, Arnau JM. Pseudomonas aeruginosa resistance to ceftazidime. Ann Pharmacother 1991;25:871.
16. 16. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
17. 17. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebseilla pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
18. 18. Richard P, Delangle MH, Merrien D, et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis 1994;19: 54-9.
19. 19. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 1994;330:1240-1.
20. 20. Jacobson KL, Cohen SH, Inciardi JF, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase producing organisms. Clin Infect Dis 1995;21:1107-13.
21. 21. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337:441-6.
22. 22. Daschner F, Langmaak H, Wiedemann B. Antibiotic resistance in intensive care unit areas. Infect Control 1983;4:382-7.
23. 23. Levine JF, Maslow MJ, Leibowitz RE, et al. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis 1985;151:295-300.
24. 24. Søgaard H, Zimmermann-Nielsen C, Siboni K. Antibiotic-resistant gram-negative bacilli in a urological ward for male patients during a nine-year period: relationship to antibiotic consumption. J Infect Dis 1974; 130:646-50.
25. 25. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992;15:37S-42S.
26. 26. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
27. 27. Stratton CW, Johnston PE, Haas DW. Lack of correlation between use of specific fluoroquinolone and the emergence of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa: a tale of two hospitals. Antimicrobics and Infectious Diseases Newsletter 1994;13:25-9.
28. 28. Ma MY, Goldstein EJ, Friedman MH, Anderson MS, Mulligan ME. Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother 1983;24:347-52.
29. 29. Mouton RP, Glerum JH, van Loenen AC. Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens a seven-year survey. J Antimicrob Chemother 1976;2:9-19.
30. 30. Møller JK. Antimicrobial usage and microbial resistance in a university hospital during a seven-year period. J Antimicrob Chemother 1989;24: 983-92.
31. 31. Søgaard P. The epidemiology of antibiotic resistance in three species of the Enterobacteriaccae and the relation to consumption of antimicrobial agents in Odense University Hospital. Dan Med Bull 1989;36:65-84.
32. 32. McGowan JE. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NY Acad Med 1987;63:253-68.
33. 33. Gaynes R. Surveillance of antibiotic resistance: learning to live with bias. Infect Control Hosp Epidemiol 1995;16:623-6.
34. 34. Pallares R, Dick R, Wenzel RP, Adams JR, Nettleman MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978-1992). Infect Control Hosp Epidemiol 1993;14: 376-82.
35. 35. Snydman DR, Griffith J. Risk factors for antimicrobial resistance and clinical significance of gram-negative organisms isolated from patients receiving intensive care [abstract no C-47]. In: Programs and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
36. 36. Manian FA, Meyer L, Jenne J, Owen A, Taff T. Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units. Infect Control Hosp Epidemiol 1996; 17:222-6.
37. 37. White RL, Friedrich LV, Kays MB, Brown EW, Scott LE. Effect of removing duplicate isolates on susceptibility reports [abstract no C-123]. In: Program and abstracts of the 91st Annual Meeting of the American Society for Microbiology (Dallas). Washington, DC: American Society for Microbiology, 1991.
38. 38. Antia R, Pilyugin S. Mathematical models for the epidemiology of antimicrobial resistance [abstract no S-58]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996.